Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Coukos

Showing results (11-20 of 355) with videos related to

Pageof 36
Sort By:
Nature Reviews. Immunology|September 24, 2011
The parallel lives of angiogenesis and immunosuppression: cancer and other talesGregory T Motz, George Coukos
Current Opinion in Immunology|May 8, 2016
Mass spectrometry-based antigen discovery for cancer immunotherapyMichal Bassani-Sternberg, George Coukos
Nature|December 14, 2022
Genetics and anatomy sculpt immune-cell partners of ovarian cancerDenarda Dangaj Laniti, George Coukos
Best Practice & Research. Clinical Obstetrics & Gynaecology|November 5, 2002
Prophylactic oophorectomyGeorge Coukos, Stephen C Rubin
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2022
Trabectedin and Durvalumab Combination Is Feasible and Active in Relapsing Ovarian CancerAntonia Digklia, George Coukos, Krisztian Homicsko
Clinical and Translational Medicine|January 11, 2023
Towards next-generation TIL therapy: TILs enriched in neoepitope-specific T cellsMarion Arnaud, George Coukos, Alexandre Harari
Nature|December 24, 2011
Cancer immunotherapy comes of ageIra Mellman, George Coukos, Glenn Dranoff
Frontiers in Immunology|July 23, 2020
Neoantigen-Specific Adoptive Cell Therapies for Cancer: Making T-Cell Products More PersonalValentina Bianchi, Alexandre Harari, George Coukos
Nature Reviews. Immunology|June 27, 2025
Tumour-associated vasculature in T cell homing and immunity: opportunities for cancer therapyEvripidis Lanitis, Melita Irving, George Coukos
Oncoimmunology|July 4, 2012
Know thy enemy: Why are tumor-infiltrating regulatory T cells so deleterious?Andrea Facciabene, Stephen Santoro, George Coukos
Pageof 36

Showing results (11-20 of 355) with videos related to

Sort By:
Pageof 36
Nature Reviews. Immunology|September 24, 2011
The parallel lives of angiogenesis and immunosuppression: cancer and other talesGregory T Motz, George Coukos
Current Opinion in Immunology|May 8, 2016
Mass spectrometry-based antigen discovery for cancer immunotherapyMichal Bassani-Sternberg, George Coukos
Nature|December 14, 2022
Genetics and anatomy sculpt immune-cell partners of ovarian cancerDenarda Dangaj Laniti, George Coukos
Best Practice & Research. Clinical Obstetrics & Gynaecology|November 5, 2002
Prophylactic oophorectomyGeorge Coukos, Stephen C Rubin
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2022
Trabectedin and Durvalumab Combination Is Feasible and Active in Relapsing Ovarian CancerAntonia Digklia, George Coukos, Krisztian Homicsko
Clinical and Translational Medicine|January 11, 2023
Towards next-generation TIL therapy: TILs enriched in neoepitope-specific T cellsMarion Arnaud, George Coukos, Alexandre Harari
Nature|December 24, 2011
Cancer immunotherapy comes of ageIra Mellman, George Coukos, Glenn Dranoff
Frontiers in Immunology|July 23, 2020
Neoantigen-Specific Adoptive Cell Therapies for Cancer: Making T-Cell Products More PersonalValentina Bianchi, Alexandre Harari, George Coukos
Nature Reviews. Immunology|June 27, 2025
Tumour-associated vasculature in T cell homing and immunity: opportunities for cancer therapyEvripidis Lanitis, Melita Irving, George Coukos
Oncoimmunology|July 4, 2012
Know thy enemy: Why are tumor-infiltrating regulatory T cells so deleterious?Andrea Facciabene, Stephen Santoro, George Coukos
Pageof 36